Literature DB >> 21799258

Lamins, laminopathies and disease mechanisms: possible role for proteasomal degradation of key regulatory proteins.

Veena K Parnaik1, Pankaj Chaturvedi, B Muralikrishna.   

Abstract

Lamins are major structural proteins of the nucleus and are essential for nuclear integrity and organization of nuclear functions. Mutations in the human lamin genes lead to highly degenerative genetic diseases that affect a number of different tissues such as muscle, adipose or neuronal tissues, or cause premature ageing syndromes. New findings on the role of lamins in cellular signalling pathways, as well as in ubiquitin-mediated proteasomal degradation, have given important insights into possible mechanisms of pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21799258     DOI: 10.1007/s12038-011-9085-2

Source DB:  PubMed          Journal:  J Biosci        ISSN: 0250-5991            Impact factor:   1.826


  84 in total

1.  Nuclear lamin A/C R482Q mutation in canadian kindreds with Dunnigan-type familial partial lipodystrophy.

Authors:  H Cao; R A Hegele
Journal:  Hum Mol Genet       Date:  2000-01-01       Impact factor: 6.150

2.  Lamin a truncation in Hutchinson-Gilford progeria.

Authors:  Annachiara De Sandre-Giovannoli; Rafaëlle Bernard; Pierre Cau; Claire Navarro; Jeanne Amiel; Irène Boccaccio; Stanislas Lyonnet; Colin L Stewart; Arnold Munnich; Martine Le Merrer; Nicolas Lévy
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

3.  Lamin C and chromatin organization in Drosophila.

Authors:  B V Gurudatta; L S Shashidhara; Veena K Parnaik
Journal:  J Genet       Date:  2010-04       Impact factor: 1.166

4.  Dynamic complexes of A-type lamins and emerin influence adipogenic capacity of the cell via nucleocytoplasmic distribution of beta-catenin.

Authors:  Katarzyna Tilgner; Kamila Wojciechowicz; Colin Jahoda; Christopher Hutchison; Ewa Markiewicz
Journal:  J Cell Sci       Date:  2009-01-06       Impact factor: 5.285

5.  Mutant nuclear lamin A leads to progressive alterations of epigenetic control in premature aging.

Authors:  Dale K Shumaker; Thomas Dechat; Alexander Kohlmaier; Stephen A Adam; Matthew R Bozovsky; Michael R Erdos; Maria Eriksson; Anne E Goldman; Satya Khuon; Francis S Collins; Thomas Jenuwein; Robert D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-31       Impact factor: 11.205

6.  Pathology and nuclear abnormalities in hearts of transgenic mice expressing M371K lamin A encoded by an LMNA mutation causing Emery-Dreifuss muscular dystrophy.

Authors:  Yuexia Wang; Alan J Herron; Howard J Worman
Journal:  Hum Mol Genet       Date:  2006-07-06       Impact factor: 6.150

7.  Loss of ZMPSTE24 (FACE-1) causes autosomal recessive restrictive dermopathy and accumulation of Lamin A precursors.

Authors:  Claire L Navarro; Juan Cadiñanos; Annachiara De Sandre-Giovannoli; Rafaëlle Bernard; Sébastien Courrier; Irène Boccaccio; Amandine Boyer; Wim J Kleijer; Anja Wagner; Fabienne Giuliano; Frits A Beemer; Jose M Freije; Pierre Cau; Raoul C M Hennekam; Carlos López-Otín; Catherine Badens; Nicolas Lévy
Journal:  Hum Mol Genet       Date:  2005-04-20       Impact factor: 6.150

Review 8.  A nuclear-envelope bridge positions nuclei and moves chromosomes.

Authors:  Daniel A Starr
Journal:  J Cell Sci       Date:  2009-03-01       Impact factor: 5.285

9.  Nuclear envelope defects associated with LMNA mutations cause dilated cardiomyopathy and Emery-Dreifuss muscular dystrophy.

Authors:  W H Raharjo; P Enarson; T Sullivan; C L Stewart; B Burke
Journal:  J Cell Sci       Date:  2001-12       Impact factor: 5.285

10.  Dynamic properties of nuclear lamins: lamin B is associated with sites of DNA replication.

Authors:  R D Moir; M Montag-Lowy; R D Goldman
Journal:  J Cell Biol       Date:  1994-06       Impact factor: 10.539

View more
  9 in total

1.  Lamin misexpression upregulates three distinct ubiquitin ligase systems that degrade ATR kinase in HeLa cells.

Authors:  Bhattiprolu Muralikrishna; Pankaj Chaturvedi; Kirti Sinha; Veena K Parnaik
Journal:  Mol Cell Biochem       Date:  2012-03-01       Impact factor: 3.396

Review 2.  Recent advances in understanding nuclear size and shape.

Authors:  Richik N Mukherjee; Pan Chen; Daniel L Levy
Journal:  Nucleus       Date:  2016-03-10       Impact factor: 4.197

Review 3.  Post-Translational Modification of Lamins: Mechanisms and Functions.

Authors:  Mingyue Zheng; Guoxiang Jin; Zhongjun Zhou
Journal:  Front Cell Dev Biol       Date:  2022-05-17

Review 4.  Use of Xenopus cell-free extracts to study size regulation of subcellular structures.

Authors:  Predrag Jevtić; Ana Milunović-Jevtić; Matthew R Dilsaver; Jesse C Gatlin; Daniel L Levy
Journal:  Int J Dev Biol       Date:  2016       Impact factor: 2.203

Review 5.  Breaking down protein degradation mechanisms in cardiac muscle.

Authors:  Robert C Lyon; Stephan Lange; Farah Sheikh
Journal:  Trends Mol Med       Date:  2013-02-27       Impact factor: 11.951

Review 6.  When lamins go bad: nuclear structure and disease.

Authors:  Katherine H Schreiber; Brian K Kennedy
Journal:  Cell       Date:  2013-03-14       Impact factor: 41.582

7.  Sustained accumulation of prelamin A and depletion of lamin A/C both cause oxidative stress and mitochondrial dysfunction but induce different cell fates.

Authors:  Tom Sieprath; Tobias D J Corne; Marco Nooteboom; Charlotte Grootaert; Andreja Rajkovic; Benjamin Buysschaert; Joke Robijns; Jos L V Broers; Frans C S Ramaekers; Werner J H Koopman; Peter H G M Willems; Winnok H De Vos
Journal:  Nucleus       Date:  2015-05-21       Impact factor: 4.197

8.  Ubiquitin ligase RNF123 mediates degradation of heterochromatin protein 1α and β in lamin A/C knock-down cells.

Authors:  Pankaj Chaturvedi; Richa Khanna; Veena K Parnaik
Journal:  PLoS One       Date:  2012-10-15       Impact factor: 3.240

9.  Lamin A/C haploinsufficiency modulates the differentiation potential of mouse embryonic stem cells.

Authors:  Poonam Sehgal; Pankaj Chaturvedi; R Ileng Kumaran; Satish Kumar; Veena K Parnaik
Journal:  PLoS One       Date:  2013-02-25       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.